Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 296.50
Bid: 297.50
Ask: 300.00
Change: -6.00 (-1.98%)
Spread: 2.50 (0.84%)
Open: 313.00
High: 313.50
Low: 296.50
Prev. Close: 302.50
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

2 Aug 2007 15:38

Oxford Biomedica PLC02 August 2007 TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to whichvoting rights are attached (ii): Oxford BioMedica PLC 2. Reason for the notification (please state Yes/No): ( ) An acquisition or disposal of voting rights: (Yes) An acquisition or disposal of financial instruments which may result in theacquisition of shares already issued to which voting rights are attached: ( ) An event changing the breakdown of voting rights: ( ) Other (please specify) : ( ) 3. Full name of person(s) subject to the notification obligation (iii): Man Financial Limited 4. Full name of shareholder(s) (if different from 3.) (iv): 5. Date of the transaction (and date on which the threshold is crossed orreached if different) (v): 1 August 2007 6. Date on which issuer notified: 2 August 2007 7. Threshold(s) that is/are crossed or reached: 3% to 2% 8. Notified details: Below 3% A: Voting rights attached to shares Class/type of shares if possible using Situation previous to the Triggering transactionthe ISIN CODE (vi) Number of shares Number of voting Rights (viii) GB0006648157 21,070,855 21,070,855 Resulting situation after the triggering transaction (vii)Class/type of shares if Number of shares Number of voting rights (ix) % of voting rightspossible using the ISINCODE Direct Direct (x) Indirect (xi) Direct Indirect GB0006648157 Below 3% Below 3% Below 3% B: Financial Instruments Resulting situation after the triggering transaction (xii)Type of Expiration Date ( Exercise/Conversion Number of voting rights % of voting rightsfinancial xiii) Period/Date (xiv) that may be acquired ifinstrument the instrument is exercised/ converted. N/A N/A N/A N/A N/A Total (A+B) Number of voting rights % of voting rights 15,634,634 Below 3% 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable (xv): Proxy Voting: 10. Name of the proxy holder: N/A 11. Number of voting rights proxy holder will cease to hold: N/A 12. Date on which proxy holder will cease to hold voting rights: N/A 13. Additional information: None 14. Contact name: Andrew Wood 15. Contact telephone number: 01865 783000 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
23rd Apr 201811:46 amRNSDirector Dealings / Market Share Purchase
11th Apr 20182:11 pmRNSDirector Dealings / Market Share Purchase
9th Apr 20185:39 pmRNSDirector/PDMR Shareholding
9th Apr 201810:47 amRNSDirector/PDMR Shareholding
5th Apr 201812:08 pmRNSDirector/PDMR Shareholding
3rd Apr 20189:45 amRNSTotal Voting Rights
22nd Mar 201811:05 amRNSDirector/PDMR Shareholding
20th Mar 20187:15 amRNSHardman & Co Res: Supply to meet demand
15th Mar 20187:01 amRNSBoard Change
15th Mar 20187:01 amRNSPreliminary Results
9th Mar 20186:41 pmRNSResult of Placing
9th Mar 20183:42 pmRNSPROPOSED PLACING TO RAISE APPROXIMATELY £20.5M
9th Mar 20183:17 pmRNSPROPOSED PLACING TO RAISE APPROXIMATELY £20.5M
1st Mar 20189:33 amRNSTotal Voting Rights
28th Feb 20187:15 amRNSHardman & Co Res: BIVV deal establishes structure
23rd Feb 20182:03 pmRNSDirector/PDMR Shareholding
20th Feb 20182:12 pmRNSHoldings in Company
15th Feb 20187:00 amRNSBioverativ Collaboration and Licence Agreement
1st Feb 201811:28 amRNSTotal Voting Rights
23rd Jan 20189:45 amRNS£3 million Innovate UK grant
23rd Jan 20189:30 amRNSDirector Dealings / Market Share Purchase
17th Jan 20187:00 amRNSKymriah receives Priority Review for adult DLBCL
9th Jan 20189:54 amRNSBLOCK LISTING RETURN
9th Jan 20189:54 amRNSBLOCK LISTING RETURN
3rd Jan 20181:33 pmRNSHolding(s) in Company
2nd Jan 20189:49 amRNSTotal Voting Rights
20th Dec 201711:22 amRNSDirector Dealings / Market Share Purchase
11th Dec 20177:08 amRNSPrimary analysis results from JULIET trial
1st Dec 201710:16 amRNSTotal Voting Rights
23rd Nov 201711:29 amRNSDirector Dealings / Market Share Purchase
9th Nov 20177:00 amRNSOXB to present at Jefferies Healthcare Conference
6th Nov 201712:06 pmRNSHoldings in Company
6th Nov 20177:37 amRNSCTL019 MAA submission to the EMA
1st Nov 20179:19 amRNSTotal Voting Rights
31st Oct 20174:01 pmRNSKymriah submitted to FDA for adults with r/r DLBCL
23rd Oct 201711:27 amRNSDirector Dealings / Market Share Purchase
2nd Oct 201711:21 amRNSTotal Voting Rights
26th Sep 20172:55 pmRNSDirector Dealings / Market Share Purchase
26th Sep 20179:37 amRNSLong Term Incentive Plan Option Grant
25th Sep 20173:05 pmRNSBlock listing application
25th Sep 20179:46 amRNSCantor Fitzgerald Healthcare Conference 2017
22nd Sep 201712:36 pmRNSDirector Dealings
20th Sep 20173:25 pmRNSHolding(s) in Company
19th Sep 20178:58 amRNSDirector Dealings
15th Sep 20179:21 amRNSDirector/PDMR Shareholding
12th Sep 20177:15 amRNSHardman Research: New advanced therapies era
7th Sep 201710:11 amRNSHoldings in Company
5th Sep 201711:45 amRNSDirector/PDMR Shareholding
5th Sep 201711:39 amRNSDirector/PDMR Shareholding
5th Sep 20177:00 amRNSOXB to Present at Rodman & Renshaw Conference

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.